Prolonged recurrence-free survival by autologous rectronectin-activated killer (RAK) cells in resected high-risk hepatocellular carcinoma: an experimental single-arm phase II trial (pilot study).
- DOI
- 10.1097/js9.0000000000002417
- Published
- 2025 Jul 1
- Container
- International journal of surgery (London, England)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/js9.0000000000002417,
title = {Prolonged recurrence-free survival by autologous rectronectin-activated killer (RAK) cells in resected high-risk hepatocellular carcinoma: an experimental single-arm phase II trial (pilot study).},
author = {Wang Y and Xu J and Zhang L and Tong J and Liu C and Li W and Zhang Q and Cao D and Chen X and Zuo W and Cao L and Zhou J and Ma J},
year = {2025},
journal = {International journal of surgery (London, England)},
doi = {10.1097/js9.0000000000002417},
url = {https://doi.org/10.1097/js9.0000000000002417}
}RIS
TY - JOUR TI - Prolonged recurrence-free survival by autologous rectronectin-activated killer (RAK) cells in resected high-risk hepatocellular carcinoma: an experimental single-arm phase II trial (pilot study). AU - Wang Y AU - Xu J AU - Zhang L AU - Tong J AU - Liu C AU - Li W AU - Zhang Q AU - Cao D AU - Chen X AU - Zuo W AU - Cao L AU - Zhou J AU - Ma J PY - 2025 JO - International journal of surgery (London, England) DO - 10.1097/js9.0000000000002417 UR - https://doi.org/10.1097/js9.0000000000002417 ER -
APA
Y, W., J, X., L, Z., J, T., C, L., W, L., Q, Z., D, C., X, C., W, Z., L, C., J, Z., & J, M. (2025). Prolonged recurrence-free survival by autologous rectronectin-activated killer (RAK) cells in resected high-risk hepatocellular carcinoma: an experimental single-arm phase II trial (pilot study).. International journal of surgery (London, England). https://doi.org/10.1097/js9.0000000000002417
Source records
- pubmed · retrieved 2026-09-26T11:30:30.315Z
- europe-pmc · retrieved 2026-09-26T11:30:30.310Z